The pharmaceutical landscape for diabetes is evolving, and transdermal GLP-1 delivery systems represent a potential breakthrough. Unlike subcutaneous injections, this approach offers a more convenient way to https://loridwst225295.loginblogin.com/49117318/glp-1-patches-a-new-approach-to-blood-sugar-control